Altimmune Cash Flow Statement (2010-2025) | ALT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-14.86M	-24.83M	-33.51M	-5.38M	-19.54M	-20.13M	-23.52M	51.09M	-20.09M	-16.17M	-20.67M	-8.89M	-24.39M	-24.64M	-22.84M	65.22M	-19.57M	-22.15M	-19.01M	-23.83M
Depreciation and Depletion (Quarter)	0.10M	0.07M	0.10M	0.20M	0.10M				0.12M	0.12M	0.12M	0.14M	0.11M	0.06M	0.04M	0.03M	0.03M	0.03M	0.03M	0.01M
Share-based Compensation (Quarter)	1.22M	1.49M	1.50M	1.32M	2.03M	2.05M	2.13M	1.89M	2.67M	2.79M	2.71M	2.47M	3.65M	4.31M	3.08M	3.35M	4.01M	3.57M	3.55M	4.94M
Deferred Taxes (Quarter)																	-0.68M
Gains from Sales and Divestitures (Quarter)				0.00M		0.04M	0.05M	0.07M		0.10M	0.10M	0.12M		0.29M	0.29M	0.29M			0.27M	0.29M
Gains from Investment Securities (Quarter)	0.88M	0.01M	2.61M	-0.86M	-1.78M	3.36M	3.53M	0.43M	4.48M	4.83M	5.08M	0.04M	0.60M	0.26M	1.82M	0.00M	8.43M	1.95M	2.67M	0.03M
Asset Writedowns and Impairment (Quarter)		8.07M	0.03M	3.30M
Cash from Restructuring (Quarter)
Non-cash Items (Quarter)	16.65M	0.86M	0.98M	8.46M	1.27M	0.00M	1.38M	25.72M	1.84M	0.73M	2.26M	16.92M	2.94M	3.30M	4.16M	5.84M	4.33M	4.32M	1.08M	0.88M
Cash from Operations (Quarter)	-19.57M	-18.93M	-17.77M	-21.97M	-13.53M	-16.70M	-15.05M	-17.31M	-19.41M	-19.38M	-20.49M	-16.53M	-16.36M	-18.11M	-27.12M	-18.27M	-16.84M	-19.35M	-11.90M	-19.45M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)
Amortizatization of Intangibles (Quarter)									0.48M	0.63M	0.67M	0.69M	0.98M	1.07M	0.98M	0.82M	0.69M	0.43M	0.20M	0.91M
Amortization of Deferred Charges (Quarter)																			0.11M	0.19M
Depreciation & Amortization (CF) (Quarter)	0.07M	0.07M	0.28M	0.12M	0.12M	0.05M	-0.14M	-0.24M	-0.36M	-0.51M	-0.55M	0.14M	0.11M	0.06M	0.04M	0.03M	0.03M	0.03M	0.03M	0.01M
Change in Working Capital
Change in Receivables (Quarter)	0.19M	-0.10M	-3.13M	-1.15M	-0.24M	0.00M	0.44M	-0.46M	0.08M	-0.12M	0.74M	0.23M	-0.80M	0.12M	0.00M	0.12M	-0.04M	-0.19M	0.52M	0.37M
Change in Account Payables (Quarter)	-0.19M	1.00M	-1.42M	2.03M	0.17M	0.67M	-1.45M	3.38M	0.43M	-1.20M	-0.99M	-0.98M	1.69M	-1.07M	-1.55M	-0.92M	0.87M	-0.23M	3.95M	-2.09M
Change in Accured Expenses (Quarter)	-2.19M	-1.86M	10.97M	-9.21M	2.66M	-1.53M	6.43M	-2.16M	-2.83M	-2.10M	1.62M	1.42M	-2.75M	5.01M	-4.74M	2.37M	-1.70M	-0.36M	0.10M	4.35M
Change in Taxes (Quarter)	0.14M	-1.01M	2.59M
Investing Activities
Capital Expenditures (Quarter)	4.21M	7.69M	0.07M	0.15M	0.01M	0.02M	0.06M	0.04M	0.05M	-0.00M										0.00M
Sales of Property, Plant and Equipment (Quarter)
Change in Intangibles (Quarter)	0.06M	0.08M	0.04M	0.01M
Change in Acquisitions & Divestments (Quarter)	30.91M	32.80M	18.69M	25.02M					34.56M	26.00M	15.98M	25.87M	14.00M	19.50M	27.00M	26.84M	38.04M	105.55M		9.40M
Cash from Investing Activities (Quarter)	19.16M	25.08M	18.41M	24.87M	-0.01M	-48.97M	-25.40M	0.98M	13.30M	3.99M	4.40M	-7.96M	-39.52M	-3.70M	1.20M	13.63M	-5.10M	101.11M	-149.32M	-79.16M
Financing Activities
Other financing activities (Quarter)																			0.32M	0.35M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)																				20.00M
Long-Term Debt Repayments (Quarter)
Short-Term Debt issuances (Quarter)
Change in Capital Stock
Shares Issued (Quarter)	34.18M	18.18M		12.46M	0.11M	24.22M	-24.16M	55.98M	0.14M	13.22M	-13.14M	86.39M	0.01M	0.15M	0.18M	0.09M	0.17M	72.40M	39.52M	61.65M
Preferred Shares Issued (Quarter)
Preferred Shares Repurchased (Quarter)
Dividend Payments
Dividends Paid - Common (Quarter)
Misc.
Cash from Financing Activities (Quarter)	34.42M	18.02M	0.12M	12.54M	3.18M	21.58M	32.06M	-0.04M	-0.30M	13.06M	0.59M	72.75M	-0.26M	-0.05M	0.27M	10.09M	34.12M	52.24M	39.35M	81.13M
Exchange Rate Effect (Quarter)
Change in Cash (Quarter)	34.02M	24.17M	0.76M	15.44M	-10.35M	-44.09M	-8.39M	-16.37M	-6.41M	-2.33M	-15.50M	48.26M	-56.14M	-21.85M	-25.65M	5.45M	12.18M	134.00M	-121.87M	-17.48M
Free Cash Flow (Quarter)	-23.78M	-26.62M	-17.84M	-22.11M	-13.54M	-16.72M	-15.11M	-17.34M	-19.46M	-19.38M	-20.49M	-16.53M	-16.36M	-18.11M	-27.12M	-18.27M	-16.84M	-19.35M	-11.90M	-19.45M
Net Cash Flow (Quarter)	34.02M	24.17M	0.76M	15.44M	-10.35M	-44.09M	-8.39M	-16.37M	-6.41M	-2.33M	-15.50M	48.26M	-56.14M	-21.85M	-25.65M	5.45M	12.18M	134.00M	-121.87M	-17.48M

Research Tools

Altimmune Cash Flow Statement (2010-2025) | ALT

Create an account

Sign In

Reset Password